safetyreportid
int64 | safetyreportversion
int64 | occurcountry
string | reporttype
string | serious
string | serious_specific
string | receivedate
int64 | transmissiondate
int64 | companynumb
string | sendertype
string | senderorganization
string | patientonsetage
float64 | patientonsetageunit
string | patientsex
string | reactions
string | drugs_specific
string | drugnames
string | activesubstancenames
string | drugindications
string |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10,338,849
| 1
|
Ireland
|
Report from study
|
Yes
|
Other (Yes)
| 20,140,724
| 20,150,326
|
IE-ROCHE-1440270
|
Regulatory Authority
|
FDA-Public Use
| 30
|
Year
|
Female
|
Anaemia (Recovering / Resolving)
|
XOLAIR (Suspect), Active: OMALIZUMAB, Indication: ASTHMA, Action: Unknown
|
['xolair']
|
['omalizumab']
|
['asthma']
|
10,339,209
| 1
|
Germany
|
Other
|
No
| null | 20,140,724
| 20,150,326
|
DE-LUPIN PHARMACEUTICALS INC.-E2B_00002060
|
Regulatory Authority
|
FDA-Public Use
| null | null |
Male
|
Myalgia (Recovered / Resolved); Headache (Recovered / Resolved)
|
ATORVASTATIN (Suspect), Active: ATORVASTATIN, Indication: PRODUCT USED FOR UNKNOWN INDICATION, Action: Drug Withdrawn; EZETROL (Suspect), Active: EZETIMIBE, Indication: PRODUCT USED FOR UNKNOWN INDICATION, Action: Unknown; PRAVASTATIN (Suspect), Active: PRAVASTATIN\PRAVASTATIN SODIUM, Indication: PRODUCT USED FOR UNKNOWN INDICATION, Action: Drug Withdrawn; SIMVASTATIN. (Suspect), Active: SIMVASTATIN, Indication: PRODUCT USED FOR UNKNOWN INDICATION, Action: Drug Withdrawn; FLUVASTATIN (Suspect), Active: FLUVASTATIN SODIUM, Indication: PRODUCT USED FOR UNKNOWN INDICATION, Action: Unknown
|
['simvastatin.', 'fluvastatin', 'atorvastatin', 'pravastatin', 'ezetrol']
|
['simvastatin', 'ezetimibe', 'atorvastatin', 'fluvastatin sodium', 'pravastatin\\pravastatin sodium']
|
['product used for unknown indication']
|
10,339,215
| 1
|
United States of America
|
Report from study
|
Yes
|
Death (Yes)
| 20,140,724
| 20,150,326
|
US-SA-2014SA095852
|
Regulatory Authority
|
FDA-Public Use
| 64
|
Year
|
Male
|
Death (Fatal)
|
CAMPATH (Suspect), Active: ALEMTUZUMAB, Indication: PRODUCT USED FOR UNKNOWN INDICATION, Action: Unknown
|
['campath']
|
['alemtuzumab']
|
['product used for unknown indication']
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.